The fellowship targets early‑career researchers rather than commercial startups, so it does not directly provide non‑dilutive capital for a pre‑seed venture. However, the applicant's background in pharmacy and ML could qualify for an individual fellowship, offering valuable credibility and networking that may indirectly benefit the startup.